What Is the Significance of the IGHV Mutation Status?

As part of Patient Power’s “Ask the Expert” segment, a patient asks, “What is the significance of the IGHV mutation status? When should newly diagnosed CLL patients get this test?” Dr. Jeff Sharman, Medical Director of Hematology Research at US Oncology Network, discusses IGHV and its role in predicting prognosis and disease progression.

Get email alerts | http://www.patientpower.info/alerts

Subscribe on YouTube | http://www.youtube.com/patientpower
Like on Facebook | http://www.fb.com/patientpower.info
Follow on Twitter | http://www.twitter.com/patientpower
Follow on Google+ | http://www.google.com/+patientpowerinfo